13F filer · CIK 1993440
First Turn Management, LLC
DEL MAR, CA · filing since Q4 2023 · last filing Aug 14, 2026
Reported value
$934.7M
+$39.6M vs prior
Positions
31
New / sold out
6 / 8
Added / reduced
13 / 11
Turnover
23.6%
buys $215.7M · sells $322.6M
Top-10 weight
53.6%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | ASCENDIS PHARMA A/S | +104,877 | – | +$28.0M |
| New | VAXCYTE INC | +443,836 | – | +$25.8M |
| Added | CYTOKINETICS INC | +243,712 | +85.9% | +$20.8M |
| New | RHYTHM PHARMACEUTICALS INC | +154,018 | – | +$17.1M |
| Added | ENLIVEN THERAPEUTICS INC | +330,521 | +53.0% | +$16.8M |
| New | INHIBRX BIOSCIENCES INC | +164,783 | – | +$15.6M |
| New | ORUKA THERAPEUTICS INC | +155,343 | – | +$14.8M |
| Added | VIRIDIAN THERAPEUTICS INC | +758,663 | +83.2% | +$13.9M |
| Added | PRAXIS PRECISION MEDICINES I | +41,087 | +96.8% | +$13.8M |
| Added | CELCUITY INC | +118,523 | +56.3% | +$12.4M |
9 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Reduced | APOGEE THERAPEUTICS INC | -374,948 | -73.0% | $-49.8M |
| Reduced | NUVALENT INC | -344,046 | -92.9% | $-42.5M |
| Sold out | IDEAYA BIOSCIENCES INC | -873,838 | -100.0% | $-29.1M |
| Reduced | MIRUM PHARMACEUTICALS INC | -182,413 | -45.6% | $-21.4M |
| Sold out | ASCENDIS PHARMA A/S | -76,300 | -100.0% | $-17.5M |
| Reduced | KYMERA THERAPEUTICS INC | -152,139 | -59.7% | $-17.4M |
| Sold out | FULCRUM THERAPEUTICS INC | -2,256,109 | -100.0% | $-17.3M |
| Sold out | TERNS PHARMACEUTICALS INC | -326,694 | -100.0% | $-17.2M |
| Sold out | VERA THERAPEUTICS INC | -422,023 | -100.0% | $-17.0M |
| Sold out | NATERA INC | -81,077 | -100.0% | $-16.2M |
9 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | REVOLUTION MEDICINES INCCOM | 415,307 | $77.8M | 8.32% |
| 2 | ABIVAX SASPONSORED ADS | 489,889 | $65.3M | 6.98% |
| 3 | AXSOME THERAPEUTICS INC.COM | 218,415 | $53.5M | 5.72% |
| 4 | ENLIVEN THERAPEUTICS INCCOM | 954,360 | $48.4M | 5.18% |
| 5 | BRIDGEBIO PHARMA INCCOM | 633,364 | $47.2M | 5.05% |
| 6 | ROIVANT SCIENCES LTDSHS | 1,331,066 | $47.1M | 5.04% |
| 7 | UNITED THERAPEUTICS CORP DELCOM | 84,932 | $46.0M | 4.92% |
| 8 | CYTOKINETICS INCCOM NEW | 527,412 | $44.9M | 4.81% |
| 9 | XENON PHARMACEUTICALS INCCOM | 600,200 | $36.2M | 3.88% |
| 10 | CELCUITY INCCOM | 329,101 | $34.4M | 3.68% |
21 more rows. Subscribe for $29/month to see every row, download the data and use the API.